Synapse Medicine raises US $ 28 million to scale its medication reconciliation platform
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs
To be marketed by Strides Pharma Inc. in the US market
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
The capsules are the generic version of the reference listed drug Mycobutin
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
Subscribe To Our Newsletter & Stay Updated